ArticleThe Journal of biological chemistry2019

A specific small-molecule inhibitor of protein kinase CδI activity improves metabolic dysfunction in human adipocytes from obese individuals.

Robert Sparks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.